| abstract |
Indoximod salt compounds and prodrugs, and pharmaceutical compositions comprising indoximod salts and prodrugs, which result in higher plasma concentration and exposure to indoximod compared to direct administration of indoximod, are currently being provided in patients in need of immunosuppressive therapy. indoleamine-2,3-dioxygenase pathway, such as cancer patients or chronic infectious diseases. (Automatic translation with Google Translate, without legal value) |